文献速递皮肤肿瘤

一种用于促进皮肤鳞状细胞癌风险分层筛查的预测工具

A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous Cell Skin Cancer.
PubMed 文献 · J Invest Dermatol · 2018-07-02

研究基于Kaiser Permanente北加州医疗系统66,995例患者队列数据,开发了cSCCscore预测工具,利用患者协变量和临床病史估算3年内发生皮肤鳞状细胞癌的个人概率。患者协变量和病史解释了约75%的个体间风险变异,预测校准度中等良好,区分度AUC约85%。

要点

  • cSCCscore利用患者协变量和临床病史预测3年内发生cSCC的个人概率。
  • 患者协变量和病史解释了约75%的个体间cSCC风险变异。
  • 交叉验证AUC约85%,预测校准度中等良好。

核心结论

  • cSCCscore可促进对非西班牙裔白人cSCC风险患者进行更知情的管理。

研究设计与样本

  • 研究使用Kaiser Permanente北加州医疗系统66,995例患者的队列数据估计统计模型参数,开发cSCCscore预测工具。

主要发现

  • 患者协变量和病史解释了约75%的个体间cSCC风险变异。
  • 交叉验证性能显示cSCCscore预测对患者观察到的cSCC发生率校准度中等良好。
  • cSCCscore在区分风险分配后3年内是否发生新原发cSCC方面表现良好,受试者工作特征曲线下面积约85%。

临床怎么用

  • cSCCscore预测可在https://researchapps.github.io/cSCCscore/获取。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cutaneous squamous cell cancers (cSCCs) present an under-recognized health issue among non-Hispanic whites, one that is likely to increase as populations age. cSCC risks vary considerably among non-Hispanic whites, and this heterogeneity indicates the need for risk-stratified screening strategies that are guided by patients' personal characteristics and clinical histories. Here we describe cSCCscore, a prediction tool that uses patients' covariates and clinical histories to assign them personal probabilities of developing cSCCs within 3 years after risk assessment. cSCCscore uses a statistical model for the occurrence and timing of a patient's cSCCs, whose parameters we estimated using cohort data from 66,995 patients in the Kaiser Permanente Northern California healthcare system. We found that patients' covariates and histories explained approximately 75% of their interpersonal cSCC risk variation. Using cross-validated performance measures, we also found cSCCscore's predictions to be moderately well calibrated to the patients' observed cSCC incidence. Moreover, cSCCscore discriminated well between patients who subsequently did and did not develop a new primary cSCC within 3 years after risk assignment, with area under the receiver operating characteristic curve of approximately 85%. Thus, cSCCscore can facilitate more informed management of non-Hispanic white patients at cSCC risk. cSCCscore's predictions are available at https://researchapps.github.io/cSCCscore/.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Wang W, Jorgenson E, Ioannidis NM, et al. A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous Cell Skin Cancer. J Invest Dermatol. 2018. PMID: 30472995. doi:10.1016/j.jid.2018.03.1528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。